Allspring Global Investments’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-124
Closed -$3.95K 2485
2023
Q3
$3.95K Sell
124
-562
-82% -$17.9K ﹤0.01% 2679
2023
Q2
$27.6K Sell
686
-735
-52% -$29.5K ﹤0.01% 2409
2023
Q1
$60.7K Sell
1,421
-682
-32% -$29.1K ﹤0.01% 2218
2022
Q4
$101K Sell
2,103
-46
-2% -$2.21K ﹤0.01% 2074
2022
Q3
$80K Buy
+2,149
New +$80K ﹤0.01% 2162